What Is the Prognosis for People with Hepatitis C? (1:33)
Oral medications for hepatitis C have high success rates, but the drugs are very expensive, says internal medicine specialist Michael Roizen, MD. Watch him explain how insurance and preventive measures can improve the prognosis for hep C patients.
Michael Roizen, MD, Sharecare Editorial Advisory member, is board certified in both anesthesiology and internal medicine and is a co-founder of RealAge. He's also a New York Times best selling author and frequent guest on the Dr. Oz Show.
